Discontinued — last reported Q4 '25
Ciena Interest Paid decreased by 0.6% to $16.88M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 34.0%, from $25.56M to $16.88M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 30.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.44M | $7.47M | $7.67M | $9.14M | $8.01M | $17.99M | $10.54M | $26.98M | $19.20M | $27.76M | $18.58M | $27.20M | $19.22M | $27.52M | $25.56M | $17.64M | $25.04M | $16.97M | $16.88M |
| QoQ Change | — | +0.4% | +2.6% | +19.2% | -12.3% | +124.5% | -41.4% | +156.1% | -28.8% | +44.6% | -33.1% | +46.4% | -29.3% | +43.2% | -7.1% | -31.0% | +42.0% | -32.2% | -0.6% |
| YoY Change | — | — | — | — | +7.7% | +140.8% | +37.4% | +195.2% | +139.5% | +54.3% | +76.4% | +0.8% | +0.1% | -0.9% | +37.5% | -35.1% | +30.3% | -38.3% | -34.0% |